Geerard L. Beets

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

Monique Maas, Patty J. Nelemans, Vincenzo Valentini et al. · The Lancet Oncology · 2010 · 1.9K citations

Surgical Oncology, Radiation Therapy, Individual Patient Data +11

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.5K citations · Full text

Surgical Oncology, Radiation Therapy, Gastrointestinal Oncology +9

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein et al. · Annals of Oncology · 2012 · 1.5K citations · Full text

Esmo Consensus Guidelines, Personalized Approach, Gastrointestinal Oncology +9

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers

Myriam Chalabi, Lorenzo F. Fanchi, Krijn K. Dijkstra et al. · Nature Medicine · 2020 · 1.3K citations · Full text

Neoadjuvant Immunotherapy, Tumor Immunology, Cancer Immunosurveillance +11

Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer

Monique Maas, Geerard L. Beets, Doenja M. J. Lambregts et al. · Journal of Clinical Oncology · 2011 · 1.1K citations